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The genetically obese (ob/ob) mouse is a useful model for the study of the diabetogenic action of growth hormone 
(GH), because treatment of these animals with GH results in decreased responsiveness of their adipose tissue to insulin 
in vitro. Studies of the mechanisms involved in GH-induced insulin resistance using isolated adipocytes of o b / o b  mice 
have not been possible, however, because of their extreme fragility and the lack of an adequate system for the 
maintenance of these cells. This study describes a new method for the isolation of o b / o b  mouse adipocytes. The 
isolated cells are stable, viable and metabolically responsive to insulin. In addition, these adipocytes have been 
maintained in primary culture, in serum-free medium, for up to 3 days. During culture, the cells exhibit large increases 
in 12SI-hGH binding (10-20-fold) and porcine 125I-insulin binding (5-10-fold). The induction of insulin resistance by 
GH has also been demonstrated in these freshly isolated o b / o b  mouse adipocytes. The studies to date indicate that the 
o b / o b  mouse adipocyte system should provide a useful model for detailed studies of the cellular and molecular 
mechanisms of GH induced insulin resistance. 
The genetically obese (ob /ob)  mouse serves as a 
useful model for the study of the diabetogenic action of 
G H ,  because, unlike normal rodents, it responds pre- 
dictably to this anti-insulin effect of the hormone [1]. 
For example, treatment of o b / o b  mice with either na- 
tive or biosynthetic G H  has been shown to result in 
increased hyperglycemia and glucose intolerance [2]. 
Also, treatment of o b / o b  mice with reduced and S- 
carboxymethylated human growth hormone (RCM- 
hGH), a diabetogenic derivative of hGH lacking signifi- 
cant insulin-like or growth-promoting activities, resulted 
in a 3-fold increase in plasma insulin concentration and 
a decreased responsiveness of adipose tissue segments 
to insulin in vitro [1]. This induction of insulin resis- 
tance in adipose tissue, is not observed until 6 h after 
injection of the hormone [3]. The development of in- 
sulin resistance, however, could not be demonstrated in 
isolated o b / o b  mouse adipocytes [1]. It has not been 
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possible to reproduce these in vivo effects of G H  with 
G H  in vitro, as attempts to maintain o b / o b  mouse 
adipose tissue segments over extended periods of time 
have shown that the tissue deteriorates in vitro and 
looses its responsiveness to insulin [3]. Studies of the 
mechanisms involved in GH-induced insulin resistance 
in isolated o b / o b  mouse adipocytes have therefore pre- 
viously not been possible, primarily because of the 
extreme fragility of these adipocytes, and the lack of an 
adequate system for the maintenance of these cells. 
Recently, a method has been described for the isola- 
tion of rat adipocytes by mild digestion and for the 
maintenance of these cells in primary culture for several 
days [4]. This system has been used successfully for 
studies on the regulation of the insulin receptor [4] and 
for studies on the intracellular processing of G H  and its 
receptor [5-8]. The objective of this study therefore, was 
to evaluate this method for the isolation and primary 
culture of o b / o b  mouse adipocytes with a view to 
establishing a system in which the cellular mechanisms 
of G H  induced insulin resistance could be studied. 
Biosynthetic methionyl-hGH (Somatonorm ®) was 
used for the preparation of RCM-hGH as previously 
described [9]. The growth-promoting, diabetogenic, and 
insulin-like effects of RCM-hGH have previously been 
reported [9]. Genetically obese (ob /ob)  female mice 
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(C57BL/6J) were obtained from Jackson Memorial 
Laboratory and were used for experiments at 4 -6  
months of age (50-70 g body wt.). 125I-Porcine insulin 
(60-80 #Ci/lug) was prepared by the chloramine-T 
method [10]. 125I-hGH (100 /~Ci//~g) was prepared by 
the lactoperoxidase method [11], and purified on a 
Sephadex G-75 column to yield a peak of monomeric 
(Mol. Wt. 22 000) 125I-hGH. 
Acutely isolated adipocytes were obtained using a 
modification of the method of Marshall et al. [4]. Mice 
were killed by decapitation and subcutaneous, perirenal 
and parametrial adipose tissue was removed. Adipose 
tissue was added to low glucose (5.6 mM) DMEM 
containing 0.25 mg /ml  collagenase (type 1) (Worthing- 
ton), 25 mM Hepes, and 40 mg /ml  BSA (fatty acid 
free) (Boehringer-Mannheim), (pH 7.4) in a total volume 
of 4 ml in polypropylene vials. The tissue was finely 
chopped, gassed with 5% C O 2 / 9 5 %  0 2 and shaken 
gently (100 rpm) at 37 °C  for 1 h. The adipocytes were 
then filtered through nylon mesh and washed three 
times in D M E M / I %  BSA (pH 7.4). The washing proce- 
dure consisted of allowing adipocytes to float to the 
surface in 50 ml culture tubes, and then removal, by 
suction, of the infranant below the cells. Cell numbers 
were determined using a hemocytometer and a scaled 
objective lens. 
Mild digestion of o b / o b  mouse adipose tissue re- 
sulted in a yield of 4.93 + 0.26- 10  6 cells/mouse (n = 84) 
corresponding to approx. 300 000 cells/g of adipose 
tissue. Adipocytes from o b / o b  mice are significantly 
larger than adipocytes from other rodents, and hence 
o b / o b  mice have a lower number of fat cells per gram 
o f  adipose tissue (approx. 1 - 10  6 cells/g) [12]. The isola- 
tion procedure used in this study therefore produces a 
reasonably high yield of cells. To determine the meta- 
bolic viability of the freshly isolated adipocytes, 
[14C]glucose oxidation was determined, in the presence 
or absence of 1 m U / m l  porcine insulin (Table I). 
Adipocytes were prepared as described and washed 
twice in low glucose (5.6 mM) D M E M / I %  BSA (pH 
7.4). The fresh cells were then aliquoted into 25 ml 
TABLE I 
Effect of insulin on D-[14C]glucose oxidaton in freshly isolated ob/ob 
mouse adipocytes 
Adipocytes were prepared and preincubated in D M E M / 1 %  BSA (pH 
7.4) for 2 h at 37°C.  D-[14ClGlucose was then added, with or without 
1 m U / m l  porcine insulin, and 14CO2 production was measured for 1 
h. The data represent mean_+ S.E. values for triplicate determinations 
in 4 experiments. The insulin effect was significant: P < 0.05, paired 
t-test 
14C02 production 
( cpm/30  000 cells per h) 
Basal 535 ± 127 
Insulin-stimulated 1003 _+ 317 
TABLE It 
Effect of RCM-hGH treatment on insulin-stimulated glucose oxidation 
The o b / o b  mice were treated subcutaneously with saline or RCM- 
hGH (200 ~ g / d a y )  for 3 days. Adipocytes were then prepared from 
subcutaneous,  perirenal and parametrial adipose tissue and D- 
[14C]glucose oxidation was measured in the presence or absence of 1 
m U / m l  porcine insulin. The data represent mean±S .E ,  values for 
triplicate determinations in 8 experiments. The effect of RCM-h GH 
was significant: P < 0.025, paired t- test  
14CO2 Production 
(% insulin stimulation over basal) 
Saline-treated 77.5 + 8.3% 
R C M - h G H  treated 42.8 + 12.3% 
flasks (300 000 cells/flask), gassed with 5 % C 0 2 / 9 5 % 0  2 
and preincubated in low glucose D M E M / I %  BSA (pH 
7.4) for 2 h at 37°C in a volume of 2 ml. Uniformly 
labeled D-[14C]glucose (0.5 ~Ci /ml)  was then added, 
with or without I m U / m l  insulin, and 14CO2 produc- 
tion was measured for 1 h. The reaction was terminated 
by acidification of the medium with 500/~1 1 M HC1 to 
release 14CO2, and the 14CO2 was collected with hy- 
amine hydroxide and counted in a scintillation spec- 
trometer. Insulin concentrations lower than 1 m U / m l  
were not used as previous studies have shown that lower 
concentrations do not yield consistent (significant) 
stimulation of glucose oxidation in adipose tissue [1]. 
The requirement for high in vitro insulin concentrations 
to produce significant stimulation of glucose oxidation 
underscores the well-known intrinsic insulin resistance 
of peripheral tissues of the o b / o b  mouse. Insulin 
stimulated basal 14CO2 production by 75 + 19% (n = 4), 
demonstrating the metabolic viability and responsive- 
ness of the cells. 
As noted earlier, treatment of o b / o b  mice with 
RCM-hGH resulted in a decreased responsiveness of 
adipose tissue segments to insulin added in vitro [1]. 
The development of insulin resistance, however, could 
not be demonstrated in isolated adipocytes [1]. We 
therefore decided to reevaluate the induction of insulin 
resistance by G H  in adipocytes prepared by our much 
milder cell isolation procedure. 
The o b / o b  mice were treated subcutaneously with 
either saline or RCM-hGH (200/~g/day) for 3 days. On 
the fourth day, the mice were fasted for 6 h prior to 
decapitation. RCM-hGH treatment of these mice in- 
creased fasting blood glucose by 58 + 18%, n = 10. 
Porcine insulin (1 m U / m l )  stimulated [14C]glucose 
oxidation in adipocytes from saline-treated mice by 
77.5 _+ 8.3% (n = 8) (Table II). RCM-hGH treatment 
significantly decreased the insulin-stimulated response 
by approx. 45% (42.8 _+ 12.3%, n = 8), demonstrating 
the induction of insulin resistance by GH. RCM-hGH 
treatment had a variable, but significant, inhibitory 
effect on basal glucose oxidation ( - 34.2 +_ 11.8%, n = 8) 
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which was not observed in studies with fat segments 
[1,3]. The reason for this difference is unclear, although 
it is evident that adipocytes from RCM-hGH-treated 
animals exhibited enhanced insulin resistance. 
Freshly isolated ob/ob adipocytes have also been 
maintained in primary culture for up to three days. 
Adipocytes were prepared as described above, except 
that cells were washed three times in culture buffer 
(DMEM containing 25 mM Hepes, 20 mM NaHCO 3, 
100 U/ml  penicillin and 100/~g/ml streptomycin (pH 
7.4) following digestion. The ob/ob mouse adipocytes 
were then suspended (1-5.10 4 cells/ml) in culture 
buffer in a total volume of 70 ml in 250 ml culture 
flasks. The cells were maintained under a CO 2 atmo- 
sphere (5% CO 2 in air) at 37°C. The adipocytes re- 
mained floating at the medium surface and did not 
attach to the culture flasks. At the end of culture, the 
medium was removed, and the cells were washed (as 
described above) in 50 ml culture tubes with culture 
buffer (without penicillin and streptomycin; pH 7.4). 
Binding studies were carded out in triplicate in 
DMEM (pH 7.4) containing 25 mM Hepes, 20 mM 
NaHCO3, 1% BSA, 125I-hGH (0.2 ng/ml, 30 000 cpm) 
or porcine 125I-insulin (2 ng/ml, 80 000 cpm) and ap- 
prox. 1 • 105 cells in a total volume of 500/xl. 125I-hGH 
binding (60 min at 37°C) and 125I-insulin binding (10 
min at 37 ° C) were performed under equilibrium condi- 
tions. Under these conditions 125I-insulin degradation 
was approx• 10% (as determined by precipitation with 
10% trichloroacetic acid), and aESI-hGH degradation 
was approx• 4%. Total cell-associated ~25I-hGH was 
determined by adding 300/~l aliquots of the cell suspen- 
sion to 100/~l dinonyl phthalate oil in a microcentrifuge 
tube and immediately centrifuging (10 000 × g, 30 s) to 
separate cell-bound aESI-hGH from free 125I-hGH in the 
aqueous medium. The cells floating at the oil-air inter- 
face were removed by slicing the top of the tube, 
through the oil, and cell-bound 125I-hGH was de- 
termined in a 7-counter. Specific binding was calculated 
as the difference in binding in the presence (nonspecific 
binding) and absence (total binding) of an excess (1 #g) 
of unlabeled hGH and has been expressed per 105 cells 
as a percentage of the 125I-hGH cpm added to each 
incubation tube. Total cell associated 125I-insulin was 
determined in an identical manner except that non- 
specificlbinding was determined in the presence of 5/~g 
of unlabeled porcine insulin. 
During culture in serum-free medium, the cells ex- 
hibited marked increases in both 125I-insulin binding 
(5-10 fold) and 125I-hGH binding (10-20 fold) (Fig. 1). 
Due presumably to the trauma of isolation, during the 
first few hours of culture, there was a significant adipo- 
cyte mortality (up to 70%) (which has also been seen 
with rat adipocytes in culture [5]), but thereafter, the 
light microscopic appearance of the cells and the cell 
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Fig. 1. Effect of culture on porcine 125I-insulin and 125I-hGH binding 
to ob /ob  mouse adipocytes. 125I-insulin binding (10 min at 37°C) 
and 125I-hGH binding (60 rain at 37°C) were performed under 
equilibrium conditions and are expressed as specific binding (% of 
total counts) per 10 5 cells. 
mained impermeable to Trypan blue for the duration of 
the culture, indicating integrity of the plasma mem- 
brane. 
These results are in agreement with other studies 
using rat adipocytes in primary culture, in which it has 
been shown that both insulin binding [4] and GH 
binding [5] increase substantially during culture of 
adipocytes in serum-free medium. The studies with rat 
adipocytes [4,5] have also shown that these increases in 
binding during culture are due to an increase in the 
number of receptors per cell with little or no change in 
binding affinity, and that the increase in the numbers of 
receptors is dependent on de novo protein synthesis [5]. 
It is likely that the increased receptor numbers dur- 
ing culture reflect a release from a down-regulated state 
induced by endogenous insulin and GH prior to the 
isolation of ob/ob mouse adipocytes. The high circulat- 
ing levels of insulin (400/~U/ml) [1] and the levels of 
GH achieved after a pulse of GH in the ob/ob mouse 
are high enough to induce maximal down regulation of 
the respective receptors. The down regulation of insulin 
receptors by physiological levels of insulin has been 
demonstrated in a variety of cell types [4, 15-19]. Simi- 
lar studies have shown the down regulation of GH 
receptors by GH (reviewed by Roupas and Herington 
[20]). In addition, many studies of GH binding and 
insulin binding to cells in culture (either primary or 
long-term) have been carried out in culture environ- 
ments dependent on the presence of fetal calf serum. 
Although fetal calf serum contains significant levels of 
bovine GH and insulin, the possible effect of these 
exogenous hormones on binding studies has been largely 
overlooked. Cultured ob/ob mouse adipocytes had a 
markedly stimulated (2-3-fold) basal rate of glucose 
metabolism, even after a few hours in culture (4 h), and 
this effect was observed at all time points tested (up to 
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24 h) (data not shown). Due to this high basal rate of 
glucose metabolism, the cultured cells could not be 
further stimulated with insulin added in vitro. This 
phenomenon has also frequently been observed with 
cultured rat adipocytes [13]. 
The exact cellular mechanisms by which GH induces 
insulin resistance remain largely unknown. For exam- 
ple, it is now well established that the hyperinsulinemia 
produced in response to the diabetogenic action of GH 
does not cause insulin resistance by down-regulating 
insulin receptors in liver and peripheral tissues (see Ref. 
21 for review). Furthermore, it has been demonstrated 
that GH does not induce insulin resistance in the o b / o b  
mouse by altering the ability of insulin to stimulate 
autophosphorylation of its receptor, indicating that GH 
does not alter the ability of insulin receptors to function 
as tyrosine kinases [22,23]. It has recently been pro- 
posed that guanine nucleotide binding proteins (G pro- 
teins) [24-26] may be involved in the signal transduc- 
tion mechanisms mediating some of the actions of in- 
sulin (e.g., via phosphatidylinositol phospholipase C). 
Recent studies from this laboratory [14] have shown 
that the in vitro action of insulin on phosphatidyl- 
inositol phospholipase C in o b / o b  mouse adipose seg- 
ments is blocked by pretreatment of the animals with 
RCM-hGH. This action of insulin on the enzyme is 
quite rapid (within 5 min). Thus, the further dissection 
of the modulation of this action of insulin on phospho- 
lipid metabolism by GH will require the use of an 
isolated cell system, in which diffusion barriers are 
minimized. 
This  study has described a new method for the 
isolation of o b / o b  mouse adipocytes. These freshly 
isolated cells are stable, viable and metabolically re- 
sponsive to insulin. In addition, freshly isolated adipo- 
cytes from RCM-hGH-treated mice exhibit enhanced 
insulin resistance. The availability of this viable and 
metabolically responsive cell system should now permit 
detailed studies of the cellular and molecular mecha- 
nisms of the induction of insulin resistance by GH. 
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